Hepion Pharm PFD (CTRVP) Stock Price, News & Analysis
What Changed
Company Description
Hepion Pharm PFD (OTC: CTRVP) is classified in the biotechnology industry within the Healthcare sector.
For FY2025, Hepion Pharm PFD reported net income of -$8.3M and diluted earnings per share of -$0.88.
This page collects what Stock Titan holds for CTRVP, including price data, SEC filings, insider trading activity, and financial highlights.
CTRVP Metrics & Rankings
Latest News
SEC Filings
Hepion Pharm PFD has filed 10 recent SEC filings, including 8 Form 4, 1 Form SCHEDULE 13D, 1 Form SCHEDULE 13G/A. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CTRVP SEC filings →
Insider Radar
| Security | Bought | Sold |
|---|---|---|
| Common shares | 200,000 $10,000 | 0 |
| Warrants | 12,700,000 $0 | 0 |
Insider buying activity at Hepion Pharm PFD over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Hepion Pharm PFD reported operating income of -$4.2M in FY2025, and net income was -$8.3M. Diluted earnings per share stood at -$0.88. The company generated -$3.3M in operating cash flow. The current ratio was 10.25, measuring current assets divided by current liabilities.
Upcoming Events
CTRVP Company Profile & Sector Positioning
Hepion Pharm PFD (CTRVP) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CTRVP often look at related companies in the same sector, including CSL Ltd (CSLLY), CSL Ltd (CMXHF), UCB SA NPV (UCBJF), UCB SA (UCBJY), and Genmab A/S DKK (GNMSF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CTRVP's relative position within its industry.